Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art
Open Access
- 28 October 2022
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2741
Abstract
There is strong evidence that homocysteine is a risk factor not only for cerebrovascular diseases but also for degenerative dementias. A recent consensus statement renewed the importance and the role of high levels of homocysteine in cognitive decline in several forms of degenerative dementia, such as Alzheimer’s disease. Although the molecular mechanisms by which homocysteine causes cell dysfunction are known, both the impact of homocysteine on specific cognitive functions and the relationship between homocysteine level and non-Alzheimer dementias have been poorly investigated. Most of the studies addressing the impact of hyperhomocysteinemia on dementias have not examined the profile of performance across different cognitive domains, and have only relied on screening tests, which provide a very general and coarse-grained picture of the cognitive status of the patients. Yet, trying to understand whether hyperhomocysteinemia is associated with the impairment of specific cognitive functions would be crucial, as it would be, in parallel, learning whether some brain circuits are particularly susceptible to the damage caused by hyperhomocysteinemia. These steps would allow one to (i) understand the actual role of homocysteine in the pathogenesis of cognitive decline and (ii) improve the diagnostic accuracy, differential diagnosis and prognostic implications. This review is aimed at exploring and revising the state of the art of these two strictly related domains. Suggestions for future research are provided.Keywords
This publication has 186 references indexed in Scilit:
- Tau and Tauopathies2012
- Homocysteine and Cognitive Function in Very Elderly Nondemented SubjectsThe American Journal of Geriatric Psychiatry, 2011
- Homocysteine effects on brain volumes mapped in 732 elderly individualsNeuroReport, 2011
- Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled TrialPLOS ONE, 2010
- Homocysteine and Hypertension in Diabetes: Does PPARHave a Regulatory Role?PPAR Research, 2010
- Update on Frontotemporal DementiaThe Neurologist, 2010
- Biochemical indicators of vitamin B 12 and folate insufficiency and cognitive declineNeurology, 2009
- Plasma Homocysteine and Risk of Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2008
- Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer DiseaseDementia and Geriatric Cognitive Disorders, 2008
- Association of Plasma Total Homocysteine Levels With Subclinical Brain InjuryArchives of Neurology, 2008